Basel Medical Ltd Ordinary Shares Statistics
Share Statistics
Basel Medical Ltd Ordinary Shares has 18.79M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 18.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 289.48K, so 1.54% of the outstanding
shares have been sold short.
| Short Interest | 289.48K |
| Short % of Shares Out | 1.54% |
| Short % of Float | 3.37% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Basel Medical Ltd Ordinary Shares.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.26,
with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.26 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 1.38 |
| Debt / FCF | 1.71 |
| Interest Coverage | 12.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $314,091.34 |
| Profits Per Employee | $64,775 |
| Employee Count | 32 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 31.21 |
Taxes
| Income Tax | 331.76K |
| Effective Tax Rate | 13.8% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Basel Medical Ltd Ordinary Shares's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.93 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 68.69 |
| Average Volume (20 Days) | 961,124 |
Income Statement
In the last 12 months, Basel Medical Ltd Ordinary Shares had revenue of 10.05M
and earned 2.07M
in profits. Earnings per share was 0.
| Revenue | 10.05M |
| Gross Profit | 7.8M |
| Operating Income | 2.2M |
| Net Income | 2.07M |
| EBITDA | 3.11M |
| EBIT | 2.58M |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 1.95M in cash and 4.29M in
debt, giving a net cash position of -2.34M.
| Cash & Cash Equivalents | 1.95M |
| Total Debt | 4.29M |
| Net Cash | -2.34M |
| Retained Earnings | 7.56M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 2.51M
and capital expenditures -7.92K, giving a free cash flow of 2.5M.
| Operating Cash Flow | 2.51M |
| Capital Expenditures | -7.92K |
| Free Cash Flow | 2.5M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
Gross margin is 77.63%, with operating and profit margins of 21.84% and 20.62%.
| Gross Margin | 77.63% |
| Operating Margin | 21.84% |
| Pretax Margin | 23.92% |
| Profit Margin | 20.62% |
| EBITDA Margin | 30.94% |
| EBIT Margin | 21.84% |
| FCF Margin | 24.89% |
